Previous Close
$20.13
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$540.2 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company'...
Community
- 0 posts discussing
0
Watchers
0
Visitors